SEARCH RESULTS FOR: "Tag: CLVS"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(2)
2019(6)
2018(5)
2017(6)
2016(15)
2015(10)
CATEGORIES
Analyst Downgrades(2)
Analyst Update(7)
Analyst Upgrades(4)
Buzz Stocks(7)
By the Numbers(1)
Earnings Preview(1)
Ezines(1)
General(2)
Intraday Option Activity(7)
Market Recap(1)
Midday Market Check(3)
Opening View(5)
Quantitative Analysis(1)
Stock Market News(5)
Stocks On the Move(7)
Technical Analysis(1)
Unusual Trading Activity(1)

2/20/2020 12:00 PM
Stocks are suddenly selling off sharply at midday, with the Dow Jones Industrial Average (DJI) down almost 300 points at last check. The losses are just as deep for the S&P 500 Index (SPX) and Nasd...
1/15/2020 9:12 AM
The shares of health care name Clovis Oncology Inc (NASDAQ:CLVS) are surging in electronic trading, following news the U.S. Food and Drug Administration (FDA) granted priority review status to its Ru...
9/24/2019 2:08 PM
SVB Leerink downgraded Clovis Oncology Inc (NASDAQ:CLVS) stock to "market perform" from "outperform," and slashed its price target by $12 to $10. The analyst in coverage called CLVS' licensing deal w...
5/29/2019 12:56 PM
This morning, Goldman Sachs weighed in on two pharma stocks, downgrading Clovis Oncology Inc (NASDAQ:CLVS) and Esperion Therapeutics Inc (NASDAQ:ESPR) to "sell." Regarding the former, Goldman believes...
4/15/2019 12:36 PM
Clovis Oncology Inc (NASDAQ:CLVS) late Friday said it was discontinuing a mid-stage trial of its lead cancer drug, rucaparib, in bladder cancer patients following the recommendation of an independent ...

Partnercenter